| 1 | Alphabet Inc | 31,127 | 9M $ | |
| 2 | ASE Technology Holding Co Ltd | 179,512 | 3.9M $ | |
| 3 | Ionis Pharmaceuticals Inc | 38,988 | 2.9M $ | |
| 4 | Neurocrine Biosciences Inc | 21,556 | 2.8M $ | |
| 5 | Axsome Therapeutics Inc | 16,401 | 2.8M $ | |
| 6 | BioMarin Pharmaceutical Inc | 48,719 | 2.8M $ | |
| 7 | Ascendis Pharma A/S | 11,828 | 2.7M $ | |
| 8 | PTC Therapeutics Inc | 39,701 | 2.7M $ | |
| 9 | Pfizer Inc | 71,313 | 2M $ | |
| 10 | Regeneron Pharmaceuticals, Inc. | 2,502 | 1.9M $ | |
| 11 | Johnson & Johnson | 7,902 | 1.9M $ | |
| 12 | Amgen Inc | 4,934 | 1.7M $ | |
| 13 | Gilead Sciences Inc | 11,961 | 1.7M $ | |
| 14 | Vertex Pharmaceuticals Inc | 3,412 | 1.5M $ | |
| 15 | UnitedHealth Group Inc | 5,216 | 1.4M $ | |
| 16 | Praxis Precision Medicines Inc | 3,855 | 1.2M $ | |
| 17 | Insmed Inc | 7,018 | 1.1M $ | |
| 18 | Protagonist Therapeutics Inc | 9,334 | 983.8K $ | |
| 19 | Belite Bio Inc | 6,004 | 957.3K $ | |
| 20 | iShares MSCI Taiwan ETF | 12,500 | 886.5K $ | |
| 21 | Moderna Inc | 17,097 | 868.5K $ | |
| 22 | Biogen Inc | 4,706 | 862.8K $ | |
| 23 | Teva Pharmaceutical Industries Ltd | 25,805 | 777.2K $ | |
| 24 | Revolution Medicines Inc | 7,971 | 775.2K $ | |
| 25 | State Street Utilities Select Sector SPDR ETF | 16,400 | 752.6K $ | |
| 26 | Octave Specialty Group Inc | 139,168 | 647.1K $ | |
| 27 | Twist Bioscience Corp | 13,476 | 640.4K $ | |
| 28 | Madrigal Pharmaceuticals Inc | 1,192 | 624K $ | |
| 29 | iShares Trust | 7,100 | 615.5K $ | |
| 30 | BioNTech SE | 6,890 | 612.4K $ | |
| 31 | Natera Inc | 2,970 | 594K $ | |
| 32 | Axogen Inc | 16,273 | 539.1K $ | |
| 33 | Select Sector Spdr Trust | 3,300 | 533.7K $ | |
| 34 | Cogent Biosciences Inc | 13,784 | 530.5K $ | |
| 35 | Select Sector Spdr Trust | 8,500 | 520.7K $ | |
| 36 | Select Sector Spdr Trust | 6,300 | 516.5K $ | |
| 37 | Cytokinetics Inc | 7,388 | 486.9K $ | |
| 38 | Genmab A/S | 16,030 | 430.1K $ | |
| 39 | Bridgebio Pharma Inc | 5,785 | 429.6K $ | |
| 40 | Tango Therapeutics Inc | 20,463 | 428.1K $ | |
| 41 | Cooper Cos Inc/The | 5,896 | 421.6K $ | |
| 42 | Eli Lilly & Co | 442 | 406.5K $ | |
| 43 | Erasca Inc | 24,847 | 402K $ | |
| 44 | Lumentum Holdings Inc | 562 | 395K $ | |
| 45 | Illumina Inc | 3,026 | 373K $ | |
| 46 | BioAge Labs Inc | 20,796 | 363.7K $ | |
| 47 | Apogee Therapeutics Inc | 4,007 | 337.3K $ | |
| 48 | ImmunityBio Inc | 41,005 | 314.5K $ | |
| 49 | United Therapeutics Corp | 527 | 312.5K $ | |
| 50 | Dyne Therapeutics Inc | 17,213 | 312.1K $ | |
| 51 | Spyre Therapeutics Inc | 6,140 | 309.7K $ | |
| 52 | Tyra Biosciences Inc | 8,075 | 309.3K $ | |
| 53 | Select Sector Spdr Trust | 6,200 | 306.1K $ | |
| 54 | State Street SPDR S&P 500 ETF Trust | 420 | 273.1K $ | |
| 55 | Alumis Inc | 12,031 | 265K $ | |
| 56 | Oruka Therapeutics Inc | 5,147 | 252.5K $ | |
| 57 | Equitable Holdings Inc | 6,794 | 252.1K $ | |
| 58 | Franklin Templeton ETF Trust | 3,700 | 252K $ | |
| 59 | Summit Therapeutics Inc | 12,136 | 230.1K $ | |
| 60 | Envista Holdings Corp | 9,001 | 228.4K $ | |
| 61 | CG oncology Inc | 3,370 | 228.1K $ | |
| 62 | Dexcom Inc | 3,628 | 227.8K $ | |
| 63 | Nektar Therapeutics | 2,830 | 203.6K $ | |
| 64 | Structure Therapeutics Inc | 4,190 | 202K $ | |
| 65 | Verastem Inc | 36,170 | 191.7K $ | |
| 66 | VanEck Gold Miners ETF/USA | 2,000 | 183.5K $ | |
| 67 | Climb Bio Inc | 24,590 | 168.4K $ | |
| 68 | United States Antimony Corp | 11,426 | 99.7K $ | |
| 69 | Alphabet Inc | 300 | 86.1K $ | |
| 70 | Iovance Biotherapeutics Inc | 19,760 | 69.4K $ | |
| 71 | Neumora Therapeutics Inc | 16,000 | 31.2K $ | |
| 72 | Brandywine Realty Trust | 10,700 | 29K $ | |
| 73 | SELECT SECTOR SPDR TRUST (THE) | 200 | 26.6K $ | |
| 74 | Plug Power Inc | 11,208 | 25.3K $ | |
| 75 | iShares Trust | 500 | 23.4K $ | |
| 76 | KraneShares CSI China Internet ETF | 400 | 11.4K $ | |